Загрузка...

Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitor.

Inhibitors of the human immunodeficiency virus type 1 protease represent a promising class of antiviral drugs for the treatment of AIDS, and several are now in clinical trials. Here, we report the in vitro selection of viral variants with decreased sensitivity to a C2-symmetric protease inhibitor (A...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ho, D D, Toyoshima, T, Mo, H, Kempf, D J, Norbeck, D, Chen, C M, Wideburg, N E, Burt, S K, Erickson, J W, Singh, M K
Формат: Artigo
Язык:Inglês
Опубликовано: 1994
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC236669/
https://ncbi.nlm.nih.gov/pubmed/8107264
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!